Extracorporeal membrane oxygenation in congenital heart disease.
Semin Perinatol
; 42(2): 104-110, 2018 Mar.
Article
en En
| MEDLINE
| ID: mdl-29305226
ABSTRACT
This review article will discuss the indications for and outcomes of neonates with congenital heart disease who receive extracorporeal membrane oxygenation (ECMO) support. Most commonly, ECMO is used as a perioperative bridge to recovery or temporary support for those after cardiac arrest or near arrest in patients with congenital or acquired heart disease. What had historically been considered a contraindication to ECMO, is evolving and more of the sickest and most complicated babies are cared for on ECMO. Given that, it is imperative for aggressive survellience for long-term morbidity in survivors, particularly neurodevelopmental outcomes.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Oxigenación por Membrana Extracorpórea
/
Cuidado Intensivo Neonatal
/
Reanimación Cardiopulmonar
/
Paro Cardíaco
/
Cardiopatías Congénitas
Tipo de estudio:
Guideline
Límite:
Humans
/
Newborn
Idioma:
En
Revista:
Semin Perinatol
Año:
2018
Tipo del documento:
Article